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AKI and CKD – making the 
diagnosis
Acute kidney injury (AKI) is serious 
and common. It complicates 1 in 7 
hospital admissions. It affects patients in 
all clinical settings, but typically develops 
first in the community either before 
prompting or becoming apparent on 
hospital admission. A recent National 
Confidential Enquiry into Patient 
Outcome and Death (NCEPOD) report 
was critical of inpatient care in AKI, citing 
delays in recognition and treatment as 
causes of preventable harm1. The diagnosis 
of AKI requires an abrupt change in serum 
creatinine or urine output presumed to 
have occurred within the past week. 
Chronic kidney disease (CKD) is a 
sustained abnormality of kidney function 
or structure. Either functional decline 
(e.g. measured with estimated glomerular 
filtration rate, eGFR) or structural change 
(e.g. albuminuria) should be evident for at 
least three months. Approximately 11.5% 
of the population meet these criteria, and 
this prevalence increases greatly with age2. 
Only a minority of patients develop end-
stage kidney disease but a much greater 
proportion suffer from complications 
including renal bone disease, anaemia, 
vascular calcification, cardiovascular 
disease and admissions with AKI. The 
Kidney Disease: Improving Global 
Outcomes (KDIGO) criteria for both 
AKI and CKD are below (Table 1).
AKI and CKD – interpreting 
the diagnosis
To correctly interpret these seemingly 
precise criteria, one must understand their 
limitations and how they are different. 
They differ not just in time frame, but 
also in the measures involved. The CKD 
criteria use eGFR, whereas the AKI 
criteria use changes in creatinine. eGFR is 
not an exact measurement of glomerular 
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Abstract
Acute kidney injury (AKI) is common and serious. While it is usually cared for in hospital, it 
is no less important in primary care. AKI typically arises first in the community and is often 
not completely resolved at hospital discharge. Primary care has a role both in prevention 
and follow up of AKI. Surveillance for new chronic kidney disease (CKD) is recommended in 
guidelines. In this article we compare the diagnostic criteria for AKI and CKD, what a diagnosis 
means in primary care, and the role of primary care in monitoring for CKD after AKI.
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filtration, but an estimation derived from serum creatinine. 
The estimate is based on the assumption that creatinine 
production from muscle and elimination in urine are in a 
steady state. In AKI this is not the case.5 
For instance, a hypothetical patient who has surgical 
removal of 1½ kidneys clearly has a sudden reduction of 
true GFR, but this will not be immediately reflected in the 
blood results. Just as a sink takes time to fill with water when 
the drain is plugged, serum creatinine will spend several 
days rising steadily until a new balance develops between 
creatinine production (the water tap) and elimination (the 
blocked drain). Estimated GFR if based on a creatinine 
taken early before this new balance has been achieved will 
not reflect the true change in GFR that has occurred. In 
practice, this means that the clinician must look not only 
at the most recent result, but also review the trend in 
changes from previous tests, particularly in a patient who is 
either acutely unwell, or recovering from an acute illness. 
This is undoubtedly easier if a patient with risk factors for 
developing AKI is already under regular surveillance (such 
as a disease register) and has those previous tests available.
AKI and CKD – an early diagnosis may 
prevent harm
The AKI and CKD criteria identify renal impairment, 
but do not explain why it has developed or what should 
be done next. They highlight the patient who is either 
acutely unwell (AKI) or could be vulnerable if they were 
to become unwell (CKD), but both the AKI and CKD 
guidelines stress that the next step should be to consider 
the underlying cause3, 4. The clinician should aim to 
address any concurrent illness (e.g. sepsis) or modifiable 
factors (e.g. non-steroidal anti-inflammatory, NSAID use) 
that might improve kidney function, prevent recurrence, 
or prevent further deterioration.
This is especially important for AKI in the hospital 
where the acutely unwell patient can quickly deteriorate if 
not recognised and sometimes a rising creatinine is the first 
signal that a patient is unwell. The same recommendations, 
however, also apply in the community. Most AKI develops 
first in the community, and patients who recover from AKI 
will eventually be discharged back into the community. 
This means that primary care has an important role in 
the primary prevention of AKI, early recognition of AKI 
when it occurs, and prevention of recurrence after patients 
return home.
However, preventing and recognising AKI is only 
possible when a clinician is aware of who is at risk and 
checks a blood test when appropriate. Helpfully, the risk 
factors for AKI and CKD progression reported in the 
National Institute for Health and Clinical Excellence 
(NICE) clinical guidelines (CG169, CG182) (Table 2) 
are strikingly similar6, 7. Both CKD and its risk factors 
substantially increase the risk of developing AKI. These are 
often patients with multi-morbidity and less physiological 
reserve who are already likely to be on a disease register 
as part of the Quality Outcomes Framework (QOF)8. A 
patient on a coronary heart disease, heart failure, stroke, 
diabetes, dementia, learning disability or CKD register, 
who presents to your clinic with an acute illness is a patient 
who may also be developing AKI.
Recognising risk after AKI – an 
uncertain period
In addition to diagnosis, another role of primary care 
is in the aftermath after AKI has occurred, as patients 
KDIGO AKI Definition KDIGO Stage Creatinine Change Urine Output
Increase in serum 
creatinine of ≥26.4µmol/l 
within 48 hours or ≥1.5 
fold rise in creatinine 
presumed within 7 days 
or urine output <0.5ml/
kg/hr for 6 hours
1 ≥26.5µmol/l or >1.5 fold rise <0.5mg/kg/hr for 6 hours
2 >2 fold rise <0.5mg/kg/hr for 12 hours
3 >3 fold rise or
creatinine≥353.6µmol/l having first met the 
definition or
Acute RRT
<0.3mg/kg/hr for 24 hours or
anuria for 12 hours
KDIGO CKD Definition KDIGO Category Functional or Structural Derangement
Evidence for > 3 months 
of at least one of:
KDIGO category G3a or 
A2 *
G1 eGFR≥ 90 ml/min/1.73m2 (normal/high)*
G2 eGFR 60-89 ml/min/1.73m2 (mild decrease)*
G3a eGFR 45-59 ml/min/1.73m2 (mild/moderate decrease)
G3b eGFR 30-44 ml/min/1.73m2 (moderate/severe decrease)
G4 eGFR 15-29 ml/min/1.73m2 (severe decrease)
G5 eGFR <15 ml/min/1.73m2 (kidney failure)
A1 Urinary ACR <3mg/mmol (normal/mild increase)*
A2 Urinary ACR 3-30mg/mmol (moderate increase)
A3 Urinary ACR >30 mg/mmol (severe increase)
*CKD can also be defined by abnormal urine sediment; electrolyte abnormality due to tubular disorder; abnormality detected by histology or 
imaging. eGFR = estimated glomerular filtration rate; ACR = albumin creatinine ratio
Table 1. AKI and CKD diagnostic criteria3, 4
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remain at risk when they return to the community. In 
the past, AKI was considered a reversible syndrome. If 
a patient survived it was once assumed that the kidney 
function would later return to a more or less acceptable 
level. This is no longer considered the case. Evidence now 
links AKI with increased mortality, progressive CKD, 
cardiovascular events and chronic dialysis requirement 
years after the initial episode9. Patients discharged 
after AKI are also at increased risk of being promptly 
readmitted10.
Recovery is not easy to interpret. The changes in 
kidney function after AKI are often complex and this is 
why close monitoring is required. In the year after an AKI 
episode, some patients will continue to improve, some 
patients will level off at a new baseline level of function 
and some patients will be vulnerable to further decline. 
This ongoing recovery or decline is in part related to 
compensatory changes in the remaining nephrons and 
changes in persisting risk factors for AKI and CKD. 
The reliability of creatinine based markers of kidney 
function can also vary. For instance, some patients 
recovering from AKI in critical illness can appear to have 
better kidney function than before their illness. This is 
deceptive and often relates to reduced muscle mass and 
reduced creatinine generation rather than improved 
glomerular filtration. Once muscle mass is later restored, 
the creatinine will paradoxically rise (and thus eGFR 
drop) even if actual kidney function has remained 
unchanged. Other factors also affect the estimation of 
kidney function and are summarised in Table 3. If the 
interpretation of creatinine is unclear (e.g. with extremes 
of muscle mass), the NICE CKD guidelines suggest 
AKI risk factors CKD progression risk 
factors
Previous AKI Previous AKI
Chronic kidney disease Hypertension and 
proteinuria
Heart failure Cardiovascular disease
Diabetes Diabetes
History of urinary tract 
obstruction
History of urinary tract 
obstruction
Recent use of NSAIDs Chronic use of NSAIDs
Liver Disease Smoking
Acute illness with sepsis, 
hypovolemia or oliguria
African, African-Caribbean 
or Asian origin
Recent drug with nephrotoxic 
potential (ACE inhibitors, 
ARBs, aminoglycosides, 
iodinated contrast)
Disability limiting access to 
fluids, or reliance on a carer
Age over 65
Table 2. Risk factors reported in the NICE clinical guidelines 
for AKI (CG169) and CKD (CG182)6, 7
GFR estimation using cystatin C for the diagnosis and 
classification of CKD, but this is not available everywhere 
and is also not perfect7.
The weeks after hospital discharge from AKI, are 
therefore critical. Some patients may have ongoing illness, 
some may be vulnerable to recurrent insults and some may 
have modifiable risk factors that have been overlooked. 
Without a carefully considered plan a patient may promptly 
be readmitted with recurrent illness, or may represent 
months later (too late) with advanced renal impairment 
that could have been avoided.
Recognising risk after AKI - the 
handover from hospital to the 
community
Patients with AKI still may be at risk after discharge, 
and they are also numerous. The majority are looked 
after by non-nephrologists while in hospital and after 
discharge very few receive outpatient nephrology follow 
up. Monitoring of kidney function after discharge should 
therefore be specifically discussed on discharge with a clear 
transfer of responsibility to ensure patients do not slip 
through the net.
Mechanism Examples
Increase in muscle creatine 
breakdown product (exogenous 
or endogenous sources)
Dietary load (meat, 
supplements)
Rhabdomyolysis
Increased muscle mass
Decrease in muscle creatine 
breakdown product
Vegetarian diet
Muscle wasting
Recent critical illness
Amputation
Increased volume of distribution 
of creatinine
Large volume fluid 
resuscitation
Congestive cardiac 
failure
Ascites
Inhibition of proximal tubule 
secretion of creatinine
Trimethoprim
Interference with creatinine 
assay
Bilirubin
Hyperglycaemia
Cephalosporins
Causes of transient Proteinuria Febrile illness (e.g. 
pneumonia)
Congestive cardiac 
failure
Urinary tract infection
Seizures
Table 3. Factors affecting the estimation of kidney function11-13
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Many AKI and CKD patients have medications 
changed while in hospital. Some drugs will have been 
stopped with permanent intent, and others with the 
intention of restarting or reviewing. Some decisions may 
involve a risk/benefit trade-off involving more than one 
specialty (e.g. ACE inhibitors in kidney disease and cardiac 
disease). Polypharmacy in CKD also can make any changes 
difficult to track.
A clear follow-up plan including medication 
reconciliation is therefore vital. Unfortunately, the 
immediate discharge letter is often written by the most 
junior, most busy, most stressed member of the medical 
team, who may not have met the patient other than to 
take their blood. Although some queries can wait until 
the finalised discharge letter, some complex decisions are 
best discussed while the patient is still fresh in the memory 
of all involved. Thus, proactive action or clarification is 
sometimes required and the sections that follow discuss 
the current recommendations and main issues that should 
be covered.
Managing risk after AKI – what is 
recommended?
Monitoring is not possible unless AKI is first recognised 
and receives good initial care. This requires an awareness 
of patients at risk and appropriate preventative measures in 
hospital and the community. Much work has been done 
recently to improve awareness and understanding of AKI, 
in particular through the NHS England “Think Kidneys” 
campaign (www.thinkkidneys.nhs.uk).
Automated e-alerts to healthcare providers when blood 
tests suggest that AKI may be present are an encouraging 
development. Automated AKI detection is already 
mandatory in NHS England hospitals and introduction 
is also intended for primary care in 2016. If accompanied 
with appropriate education this initiative has potential to 
enhance the avoidance and early recognition of AKI and 
reduce missed opportunities for timely intervention14.
In NHS England, the Commissioning for Quality and 
Innovation (CQUIN) scheme for 2015/16 now includes 
goals for acute kidney injury. Patients who have had AKI 
in hospital should have this recognised on their discharge 
summary, including stage of AKI; evidence of medications 
review and the type and frequency of blood tests required 
after discharge15. This should enhance the visibility of 
vulnerable patients returning to the community. It also 
complements the GP Quality and Outcomes Framework 
(QOF 2015/16), which encourages the identification of 
CKD in the community by requiring a register of patients 
aged 18 and over with CKD stages G3a-5 in line with the 
classification in table 18.
Both national and international guidelines recommend 
monitoring for CKD after AKI. The KDIGO AKI 
guidelines advise that all patients should be assessed at 
90 days after AKI for evidence of new or worsening 
kidney function3. The NICE CKD guidelines also advise 
that all patients who have had an episode of AKI should 
be considered at risk of developing CKD or of CKD 
progressing to a more advanced stage. They recommend 
that all patients should be monitored for at least 2-3 years 
after an AKI episode even if the creatinine has returned 
back to baseline (pre-illness) level7. They also suggest 
monitoring frequencies of at least six monthly in patients 
in categories G3b (GFR <45ml/min/1.73m2) or A3 
(albuminuria >30mg/mmol) (and more often in more 
advanced disease), but acknowledge that these can be 
tailored to the individual.
Managing risk after AKI – the post 
discharge review
The overall prognosis of AKI is of increased mortality 
and CKD progression, but the specific factors that predict 
persisting poor outcomes are the subject of ongoing 
clinical research. In addition, AKI encompasses a variety of 
illness states requiring different management approaches. 
To assist, some areas provide local guidelines for priorities 
in the post-discharge review after AKI. These may include 
items outlined in the “RISK” assessment below.
R - Renal diagnosis and cause
Most AKI is not related to renal parenchymal 
disease, but occurs in the context of acute severe illness 
including sepsis, ischaemia, bleeding, volume depletion 
and hypotension. The cause of AKI should be noted for 
future reference for two reasons. First, recurrent AKI 
often follows a similar mechanism. For instance, recurrent 
AKI after urinary obstruction requiring a ureteric stent 
may now be related to a blocked stent; or a previous AKI 
following ACE inhibitor introduction may increase the 
suspicion that recurrent AKI with pulmonary oedema is 
due to renal artery stenosis. Second, the development of 
AKI introduces the possibility of related conditions. For 
instance a smoker or a patient with diabetes who develops 
AKI may already have other undiagnosed vascular diseases.
I - Intervenable risk factors
Some AKI and CKD risk factors are recurrent or 
longstanding and can be mitigated by taking pre-emptive 
avoiding action. For instance, developing strategies to 
avoid recurrent dehydration in a patient with a high output 
stoma; or cautious adjustment of diuretics in a patient with 
congestive cardiac failure and recurrent AKI.
S - Sick day rules and medications 
review
Drugs affecting renal blood flow are frequently 
implicated in AKI. NSAIDs, renin-angiotensin system 
(RAS) blockers such as ACE inhibitors and diuretics can 
precipitate and exacerbate pre-renal AKI, particularly when 
used in combination (“the triple whammy”). NSAIDs 
should be avoided after AKI and consideration should be 
given as to whether other drugs are necessary. It would be 
appropriate to stop antihypertensive agents if the risks of 
recurrent AKI and hypotension clearly outweigh any long-
term protective benefits. In patients with an important 
indication such as those with heavy proteinuria, it may be 
advisable to continue RAS blockers and diuretics. “Sick 
day rules” have recently become popular in many areas in 
this circumstance, advocating temporary discontinuation 
in the setting of significant diarrhoea, vomiting or febrile 
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illness. While there have been encouraging reports that 
this may reduce community AKI without unintended 
consequences, an evidence base is currently outstanding 
and care may be required in some patients with cardiac 
failure.
At the time of the post-AKI review some drugs may 
have already been discontinued temporarily. The re-
introduction of antihypertensive agents and diuretics 
should be accompanied by reassessment of blood pressure 
Specialist assessment should be considered for:
GFR < 30ml/min/1.73m2, with or without diabetes
Albumin creatinine ratio ≥ 70mg/mmol, unless known to be due 
to  diabetes and on appropriate treatment
Albumin creatinine ratio ≥ 30mg/mmol with haematuria
Fall in GFR ≥ 25% with a change in GFR category, or GFR fall ≥ 15 
ml/min/1.73m2 over 12 months
Poorly controlled hypertension despite use of 4 agents at 
therapeutic doses
Suspected rare or genetic cause of CKD (e.g. primary renal 
disease)
Suspected renal artery stenosis
Table 4. Specialist referral criteria in NICE guidelines for CKD 
(CG182)7
and fluid balance. Creatinine and potassium should also 
be rechecked 1-2 weeks after any RAS blocker dose 
increase.
K - Kidney recovery or progression
Prompt recovery of kidney function back to baseline 
(pre-illness) level is associated with better outcomes after 
AKI16. Assessment should include testing both for return 
of creatinine to baseline, and for persistent proteinuria 
now that the acute illness has resolved. Monitoring for 
recovery is vital and may be used to predict and prevent 
recurrence, readmission and avoidable death. A patient 
with persisting renal impairment should prompt a 
reassessment to find out why. It may be a sign of ongoing 
acute illness, an incorrect diagnosis, an overlooked 
causative factor, or the development of CKD. The 
specific CKD referral recommendations from NICE are 
outlined in Table 4.
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Key Points Summary
• Patients with AKI come from the community and return to the community. Primary care therefore has a vital role in 
recognising AKI and preventing recurrence. 
• Care must be taken to interpret creatinine and eGFR correctly in acute illness. The change is often more important than 
the absolute value.
• Patients with AKI frequently have risk factors covered by disease registers as part of the QOF. 
• AKI is a serious illness, but patients often return to the community before recovery is complete. 
• Patients with AKI have a sustained increased risk of relapse, recurrence, CKD progression and death. 
• A good handover on discharge to primary care is essential as is included in the national CQUIN. 
• Specific management after AKI is individual to the patient, but may involve: 
1. R - confirm the renal diagnosis
2. I - address any intervenable risk factors to prevent or pre-empt recurrence
3. S - sick day rules and medications review
4. K - assess for kidney recovery or the development of new CKD
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1. A 76 year old man with a four day history of 
vomiting and profuse diarrhoea is reviewed at 
home. Past medical history includes hypertension 
and osteoarthritis of the knees. Medication 
- amlodipine, dihydrocodeine, candesartan, 
naproxen. On examination he is pyrexial, drowsy, 
with reduced skin turgor and dry mucous 
membranes. Blood pressure 96/62, HR 112 
regular. Chest is clear. He has mild abdominal 
tenderness without guarding. Blood tests include 
potassium 5.4, albumin 29, urea 27, creatinine 238, 
eGFR from lab 20. Urinalysis protein++ .His last 
creatinine was 120 more than three years ago.
 How would you classify this man’s renal 
impairment? Select only one option.
a.  Acute kidney injury
b.  Chronic kidney disease
c.  End stage kidney disease (kidney failure)
d.  Insufficient information
e.  Normal kidney function
2. A 76 year old man with a four day history of 
vomiting and profuse diarrhoea is reviewed at 
home. Past medical history includes hypertension 
and osteoarthritis of the knees. Medication 
- amlodipine, dihydrocodeine, candesartan, 
naproxen. On examination he is pyrexial, drowsy, 
with reduced skin turgor and dry mucous 
membranes. Blood pressure 96/62, HR 112 
regular. Chest is clear. He has mild abdominal 
tenderness without guarding. Blood tests include 
potassium 5.4, albumin 29, urea 27, creatinine 238, 
eGFR from lab 20. Urinalysis protein++ .His last 
creatinine was 120 more than three years ago
 Which of the following best describes the 
underlying renal diagnosis? Select only one option.
a.  Hypertensive nephropathy
b.  Nephrotic syndrome
c.  Pre-renal illness
d.  Renal artery stenosis
e.  Obstructive uropathy
3. A 76 year old man with a four day history of 
vomiting and profuse diarrhoea is reviewed at 
home. Past medical history includes hypertension 
and osteoarthritis of the knees. Medication 
- amlodipine, dihydrocodeine, candesartan, 
naproxen. On examination he is pyrexial, drowsy, 
with reduced skin turgor and dry mucous 
membranes. Blood pressure 96/62, HR 112 
regular. Chest is clear. He has mild abdominal 
tenderness without guarding. Blood tests include 
potassium 5.4, albumin 29, urea 27, creatinine 238, 
eGFR from lab 20. Urinalysis protein++ .His last 
creatinine was 120 more than three years ago
 Which of his medications should be discontinued at 
present? Select only one option
a.  Candesartan
b.  Candesartan and Naproxen
c.  Dihyrocodeine and Naproxen
d.  Amlodipine, Candesartan and Naproxen
e.  All his medications should be discontinued
4. A 78 year old man is discharged from the urology 
ward and attends your clinic for review the 
following fortnight. He had been admitted with 
kidney stones and was found to have ureteric 
obstruction. A nephrostomy was inserted, a 
ureteric stent was passed and the nephrostomy 
subsequently removed. His previous baseline 
creatinine was 96 (lab reported eGFR 70), this rose 
to 194 during admission (lab reported eGFR 31). 
His last test before discharge showed a creatinine 
of 136 (lab reported eGFR 47). Urinary dipstick 
negative.
 How would you classify this man’s renal 
impairment? Select only one option.
a.  Chronic kidney disease G3a A1
b.  Chronic kidney disease G3b A1
c.  End stage kidney disease (kidney failure)
d.  Insufficient information
e.  Normal kidney function
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5. A 78 year old man is discharged from the urology 
ward and attends your clinic for review the 
following fortnight. He had been admitted with 
kidney stones and was found to have ureteric 
obstruction. A nephrostomy was inserted, a 
ureteric stent was passed and the nephrostomy 
subsequently removed. His previous baseline 
creatinine was 96 (lab reported eGFR 70), this rose 
to 194 during admission (lab reported eGFR 31). 
His last test before discharge showed a creatinine 
of 136 (lab reported eGFR 47). Urinary dipstick 
negative.
 Prior to admission he was on furosemide 40 mg 
once daily, ramipril 10 mg once daily and ibuprofen 
400 mg three times daily. These were discontinued 
while in hospital. ALL of the following statements 
are False, except one. Select the SINGLE true 
statement.
a.  All his medications can now be safely restarted.
b.  All his medications can be restarted if his repeat 
creatinine has returned to baseline.
c.  He should restart his medications one at a time if his 
creatinine has returned to baseline.
d.  The indications for each medication should be reviewed 
in conjunction with clinical and laboratory assessment
e.  He should remain off these medications as they were not 
prescribed on his discharge letter.
6. A 78 year old man is discharged from the urology 
ward and attends your clinic for review the 
following fortnight. He had been admitted with 
kidney stones and was found to have ureteric 
obstruction. A nephrostomy was inserted, a 
ureteric stent was passed and the nephrostomy 
subsequently removed. His previous baseline 
creatinine was 96 (lab reported eGFR 70), this rose 
to 194 during admission (lab reported eGFR 31). 
His last test before discharge showed a creatinine 
of 136 (lab reported eGFR 47). Urinary dipstick 
negative.
 His repeat creatinine is 186 (lab reported eGFR 33). 
He is otherwise asymptomatic. What is the next 
most appropriate course of action? Select only one 
option
a.  Contact the urology ward to discuss readmission
b.  Maintain regular follow  up every 4 – 6 months
c.  Repeat blood test again one week
d.  Refer him for an outpatient urinary tract ultrasound
e.  Refer him to the nephrology outpatient clinic for regular 
follow up
7. A 78 year old man is discharged from the urology 
ward and attends your clinic for review the 
following fortnight. He had been admitted with 
kidney stones and was found to have ureteric 
obstruction. A nephrostomy was inserted, a 
ureteric stent was passed and the nephrostomy 
subsequently removed. His previous baseline 
creatinine was 96 (lab reported eGFR 70), this rose 
to 194 during admission (lab reported eGFR 31). 
His last test before discharge showed a creatinine 
of 136 (lab reported eGFR 47). Urinary dipstick 
negative.
 His repeat creatinine is 112. From correspondence 
you note that he has a history of moderate 
left ventricular systolic dysfunction and that 
ramipril was recommended by cardiology to be 
recommenced on discharge. Which is the most 
appropriate course of action? Select only ONE 
option.
a.  Restart ramipril at full dose and review in 3 months.
b.  Monitor blood tests weekly and restart only if creatinine 
falls below baseline.
c.  Restart ramipril if blood tests at 90 days suggest new 
onset CKD.
d.  Restart ramipril at a reduced dose and recheck blood 
tests in two days.
e.  Restart ramipril at a reduced dose and recheck blood test 
in 1-2 weeks.
8. A 58 year old woman is discharged from hospital 
after a six week admission for septic shock 
including a period of renal replacement therapy for 
severe AKI, and mechanical ventilation in intensive 
care. She is on no medication except for nutritional 
supplements and currently has a BMI of 15. Her 
creatinine on discharge was 65 (lab reported eGFR 
86) and her urinalysis is negative.
 Which of the following is MOST likely to be true 
about her current kidney function? Select only 
ONE option.
a.  Her kidney function has returned to normal
b.  Kidney function will be underestimated due to dietary 
supplements
c.  Kidney function will be overestimated due to reduced 
muscle mass
d.  Kidney function will be underestimated due to reduced 
muscle mass
e.  She has evidence of chronic kidney disease
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9. A 58 year old woman is discharged from hospital 
after a six week admission for septic shock 
including a period of renal replacement therapy for 
severe AKI, and mechanical ventilation in intensive 
care. She is on no medication except for nutritional 
supplements and currently has a BMI of 15. Her 
creatinine on discharge was 65 (lab reported eGFR 
86) and her urinalysis is negative. What further 
monitoring is recommended for this patient? 
Select only ONE option.
a.  As her kidney function has returned to baseline no 
formal monitoring is required.
b.  She should have urine and creatinine checked at 3 
months to check for new CKD. If normal then no 
further monitoring required.
c.  She should have urine and creatinine checked at 3 
months to assess for new CKD. She should be monitored 
for at least 2-3 years regardless of the result. 
d.  She should have her urine and creatinine checked in 2-3 
years.
e.  She should be monitored until her BMI has returned to 
normal.
10. A 58 year old woman is discharged from hospital 
after a six week admission for septic shock 
including a period of renal replacement therapy for 
severe AKI, and mechanical ventilation in intensive 
care. She is on no medication except for nutritional 
supplements and currently has a BMI of 15. Her 
creatinine on discharge was 65 (lab reported eGFR 
86) and her urinalysis is negative. 4 months later 
her BMI has risen to 19 and her urinalysis remains 
negative. Her creatinine is now 94 (lab reported 
eGFR 56). What is your assessment of her kidney 
function now? Select only ONE option.
a.  She has new onset chronic kidney disease.
b.  She may have new onset chronic kidney disease but 
further assessment is necessary.
c.  She has normal kidney function.
d.  She has recurrent acute kidney injury stage 1
e.  She has recurrent acute kidney injury stage 3
EXTENDED MATCHING QUESTIONS
EMQ 1
THEME: FACTORS AFFECTING ESTIMATION OF 
KIDNEY FUNCTION
 Options:
a.  Increase in creatine breakdown product
b.  Decrease in creatine breakdown product
c.  Increased volume of distribution of creatinine
d.  Inhibition of proximal tubule secretion of creatinine
e.  Interference with creatinine assay
f.  Assumption of a steady state for GFR estimation
g.  Transient abnormality in the context of underlying 
illness
 In each of the case scenarios a factor has affected 
the interpretation of kidney function tests. Match 
the scenario to the best explanation of the list of 
factors in the options given,  for the blood results 
and clinical presentation. Each option may be used 
once, more than once or not at all.
1. A 65 year old woman with recurrent urinary tract 
infections is placed on an extended course of 
trimethoprim. Creatinine rises to 102 from 67 the 
previous week.
2. An 84 year old lady is admitted obtunded with 
urinary sepsis. She is found to have AKI with 
a creatinine of 238 from normal baseline and 
is oliguric. She receives large volume fluid 
resuscitation but remains oliguric although the 
creatinine does not rise further.
3. A 60 year old receives a bilateral nephrectomy for 
renal carcinoma. 1 hour post-op he is anuric, but 
his creatinine is 102 (lab reported eGFR 51). He is 
scheduled for dialysis the following day.
4. A 62 year old man is admitted to hospital with 
sepsis and severe pneumonia. It is noted on 
admission that he has protein in his urine and this 
is sent off for quantification. His ACR (albumin/
creatinine ratio) is 18 and serum creatinine 84 (lab 
reported eGFR 85). The following week his ACR is 
<3, serum creatinine 88 (lab reported eGFR 81).
5. A 64 year old diabetic man with diabetic 
nephropathy and a baseline creatinine of 240 
presents with an ischaemic limb. Revascularisation 
is ineffective and an above knee amputation 
is performed. At discharge it is noted that his 
creatinine has fallen to 200.
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EMQ 2
THEME: RISK FACTORS AND COMPLICATIONS IN 
KIDNEY DISEASE
 Options:
a.  Vascular calcification
b.  Hypotension
c.  Proteinuria
d.  Hypoglycaemia
e.  Hyperglycaemia
f.  Liver Disease
g.  Diabetes Mellitus
h.  NSAIDs
i.  Beta blockers
j.  ACE inhibitors
 Each clinical scenario describes a risk factor or 
complication of kidney disease. Match the scenario 
to the SINGLE factor from the list of options that 
best fits the description. Each option may be used 
once, more than once or not at all.
1. A patient with CKD on ramipril and furosemide in 
the community is at particularly increased risk of 
AKI when co-prescribed this type of medication.
2. This bedside test finding is associated with CKD 
progression in the long-term, but can also be 
transiently abnormal in the context of acute febrile 
illness.
3. This drug is useful in the management of CKD 
with proteinuria in the community.
4. This is an important long term complication of 
CKD.
5. Clinicians may need to adjust medications to 
prevent this complication from occurring in 
people with type 2 diabetes mellitus who develop 
severe acute kidney injury.
EMQ 3
THEME: ASSESSMENT OF KIDNEY FUNCTION
 Options:
a.  Serum creatinine
b.  eGFR
c.  albumin creatinine ratio
d.  urinalysis
e.  ultrasound scan
f.  blood pressure
g.  urine output
h.  ECG
i.  histology
 For each scenario given describes a diagnostic test 
used to assess kidney structure or function. Select, 
from the options given, the test being described.
1. This test assumes a steady state that may not exist 
in an acute setting.
2. When available, knowledge of this is may provide 
the first measureable change suggestive of acute 
kidney injury.
3. If found to be abnormal in a patient who is not 
recovering during follow up after AKI, this 
may prompt you to consider an intrinsic renal 
abnormality.
4. This may be falsely low in the recovery phase of 
critical illness.
5. If not already done, this should be considered when 
a patient is failing to recover from AKI.
